Fig. 2: Association between neoadjuvant treatment and survival according to mismatch repair (MMR) status. | npj Precision Oncology

Fig. 2: Association between neoadjuvant treatment and survival according to mismatch repair (MMR) status.

From: Association of mismatch repair status with survival and response to neoadjuvant chemo(radio)therapy in rectal cancer

Fig. 2: Association between neoadjuvant treatment and survival according to mismatch repair (MMR) status.

a Disease-free survival (DFS), and b distant metastasis-free survival (DMFS) in patients with deficient MMR (dMMR) by neoadjuvant radiotherapy. c DFS and d Local recurrence-free survival (LRFS) in patients with stage III disease and proficient MMR (pMMR) tumors by neoadjuvant radiotherapy. NCT neoadjuvant chemotherapy, NCRT neoadjuvant chemoradiotherapy, HR hazard ratio, CI confidential interval.

Back to article page